Summary The characteristics of cell death were investigated after exposure of CCRF-CEM.f2 cells to five drugs over a broad concentration range; these were the glucocorticoid dexamethasone (DXM), the mitotic inhibitor vincristine (VIN) and three antimetabolites, methotrexate (MTX), 5'-fluoro-2'-deoxyuridine (FUdR) and 5'-fluorouracil (5-FU). Drug-treated cells were monitored for cell death mechanisms at different times by examining the pattern of DNA degradation, cell morphology and flow cytometric profile, together with effects on cell growth over 72 h. At growth-inhibitory drug concentrations, the first changes were cell cycle perturbations detectable after 4-6 h of drug exposure. The appearance of features characteristic of apoptotic cell death was noted after all drug treatments in the CCRF-CEM.f2 cell line, but the pattern and kinetics varied considerably. VIN induced apoptotic changes by 12 h, while DXM treatment caused apoptosis only after 48 h. Both MTX and FUdR induced morphological changes characteristic of apoptosis at least 24 h before internucleosomal DNA cleavage, which was detectable only after 48 h. In contrast, 5-FU did not cause internucleosomal DNA cleavage by 48 h at any concentration, despite the presence of morphologically apoptotic cells 24 h earlier. These data suggest that disruption of the cell cycle caused by drug treatment may be the common trigger initiating the drug-specific apoptotic sequence of dying cells.
Anti-cancer drug treatment of many cultured cells induces cell death by apoptosis (for reviews see Dive and Hickman, 1991; Hickman, 1992 ). How such a wide variety of drugs induce the apoptotic process is unknown, but knowledge of the sequence of molecular events causing apoptotic cell death may have implications for optimal cancer chemotherapy.
During the apoptotic process, the cell participates in its own 'suicide' by the activation of a cascade of events that leads ultimately to nuclear fragmentation, DNA degradation and the formation of apoptotic bodies, which in turn can be engulfed by macrophages or surrounding cells (Kerr et al., 1987; Wyllie, 1987; Arends et al., 1991) . Apoptosis is distinct from necrotic cell death, which is characterised by increased membrane permeability and collapse of cellular homeostasis (Wyllie, 1980) . The apoptotic mode of cell death is now usually defined by morphological criteria together with internucleosomal DNA digestion (Russell et al., 1992) . Morphologically, apoptosis is characterised by the appearance of condensed chromatin, which marginises to the nuclear membrane . The characteristic discretely digested DNA is recognised as a ladder pattern on DNA agarose gels (Wyllie, 1980; Arends et al., 1990) . Recently, flow cytometry has been used to distinguish apoptotic and necrotic cell populations (Dive et al., 1992; Hotz et al., 1992; Huschtscha et al., 1994) . The appearance of a subpopulation of small cells that has increased cellular granularity defines cells undergoing the apoptotic process. Several studies have indicated the importance of examining cytotoxic mechanisms using at least two criteria, most commonly cell morphology with DNA gel electrophoresis (McDougall et al., 1990; Russell et al., 1992; Catchpoole and Stewart, 1993; Huschtscha et al., 1995) . The results are sometimes discordant. For instance, after treatment of CCRF-CEM.f2 cells with 5'-fluorouracil (5-FU) (10-' and 10-2 M), the nuclei developed apoptotic morphology but no DNA ladders appeared on agarose gels.
In an attempt to unravel the apoptotic process, we have used three methods to monitor CCRF-CEM.f2 cells after exposure to five different drugs over a broad concentration range. The mode of cell death was studied at particular time intervals by morphological studies, DNA gel electrophoresis and by flow cytometry. The drug effects were also assessed by monitoring growth over a 3 day period. The drugs used were dexamethasone (DXM; a glucocorticoid), vincristine (VIN; a mitotic inhibitor), methotrexate (MTX; an inhibitor of dihydrofolate reductase) and the fluoropyrimidines, 5'-fluoro-2'-deoxyuridine (FUdR) and 5-FU. The first changes seen after drug treatment were cell cycle perturbations detected using flow cytometric methods. Morphological alterations typical of apoptosis appeared later and in most cases preceded the appearance of DNA ladders. Each drug showed its own pattern of changes in the CCRF-CEM.f2 cell line as judged by the above criteria.
Materials and methods

Cell culture
The acute leukaemic T-lymphocyte cell line CCRF-CEM.f2 (Foley et al., 1965) DNA gel electrophoresis DNA was isolated using the method of Miller et al. (1988) with some modifications, (see Huschtscha et al., 1994) .
Flow cytometry
Drug-treated cells were analysed by flow cytometry according to the procedure described previously (Huschtscha et al., 1994) . Drug treatment of CCRF-CEM.J2 cells CCRF-CEM.f2 cells were exposed to the five drugs over an extensive concentration range and several criteria were used to monitor changes at particular time intervals. These criteria were cell morphology, DNA gel electrophoresis and flow cytometry together with effects on cell growth. Figure 1 shows the dose-response curves of CCRF-CEM.f2 cells at 24, 48 and 72 h and demonstrates that growth inhibition is time and concentration dependent for all five drugs. Growth inhibition, that is 80% or less growth compared with control cells, is apparent after all drug exposures except for the lowest concentrations of VIN (10-' M) and DXM (10-', 106 M) (Figure 1 ). Viability studies using trypan blue mirrored the data obtained from growth curves with an increase in drug effect with higher drug concentrations and longer exposure (data not shown). Figure 4b ; Table I ) was apparent.
DXM: After 10-6_ l0-4 M DXM for 24 h cells were smaller and growth was reduced (Figure 1) . By 48 h at the higher DXM concentrations both condensation of chromatin and internucleosomal DNA cleavage were observed (Table I) . Twenty-four hours later, internucleosomal DNA cleavage was visible at all concentrations and the proportion of cells with condensed chromatin had markedly increased (Table I) . At this time, many nuclei had fragmented and the cells were clearly smaller. No significant DNA degradation or chromatin condensation was observed 24 h after DXM treatment. Flow cytometry was not performed after DXM treatments.
VIN: There were no observable changes at the lowest concentration of VIN (10O M) with respqct to cell cycle distribution, DNA degradation and cell morphology (Figure 5a , b; Table I ). Flow cytometry showed cell cycle changes 4 h after the addition of the three highest concentrations of VIN (10-8_10-6 M) with double the proportion of cells accumulated in the G2/M phase compared with control cells ( Figure  5a ). By 12 h internucleosomal cleavage was visible and after 18 h of drug exposure, the GI peak had disappeared and subpopulations of both small and large cells with apoptotic features were apparent flow cytometrically ( Figure Sb ; Table  I ). Cells accumulated in the S-phase of the cell cycle at this time. Extensive chromatin condensation was apparent by 24 h ( 
Discussion
Cell morphology, DNA agarose gels and flow cytometric methods were used to monitor the mechanisms of cell death in CCRF-CEM.f2 cells after exposure to five anti-cancer drugs. The first changes detected within a few hours of drug exposure were cell cycle perturbations visible by flow cytometry. These alterations reflected the reduced growth rate of drug-treated cells, especially at higher drug concentrations (Figure 1) (Table I) . After MTX and FUdR treatments, the appearance of morphologically apoptotic cells correlated with the appearance of a new subpopulation of cells detected by flow cytometry, and without the appearance of DNA degradation (Table I ). This observation suggests that flow cytometry detects DNA loss and chromatin condensation but internucleosomal DNA cleavage is not recognisable by this technique.
5-FU caused morphologically recognisable apoptosis as
early as 24 h after drug treatment but internucleosomal DNA cleavage was not detected at any concentration studied though a smear of DNA of different sizes was seen by 48 h (Figures 3e-h, 4b ; Table I ). In a preliminary study in which the early events were not investigated we showed that (10-3 10-2 M) 5-FU treatment of CCRF-CEM.f2 cells for 48 h caused morphological apoptosis without internucleo- somal DNA cleavage (Huschtscha et al., 1995) . These data demonstrate that 5-FU treatment of CCRF-CEM.f2 cells can initiate apoptotic events but not lead to internucleosomal DNA cleavage, which is characteristic of the later stages of apoptosis. A recent study on several cell lines in which cell death was induced by exposure to etoposide, serum deprivation or reaching confluence reported the early appearance of 50kbp fragments detected using field inversion gel electrophoresis. These fragments preceded the appearance of the oligonucleosomal 180-200 bp DNA 'ladder' characteristic of apoptosis (Oberhammer et al., 1993) . One cell line, DU-145, exhibited apoptotic morphology and 50 kbp DNA fragments but no subsequent internucleosomal cleavage was observed. It is possible that the DNA of 5-FU treated CCRF-CEM.f2 cells is cleaved initially into larger fragments, but whether -this characterises the subpopulation of smaller cells adjacent to the GI peak apparent after 24 h exposure is unknown (data not shown).
Catchpoole and Stewart (1993) compared the apoptotic process in CCRF-CEM.f2 and MOLT.4 cells after etoposide exposure. Although there were many similarities in the kinetics of etoposide effects, the apoptotic processes differed. Both cell lines exhibited apoptotic morphology but DNA fragmentation and apoptotic bodies were not evident in MOLT.4 cells. These data together with our own emphasise the importance of morphological criterion in assessing apoptosis while other methods such as DNA fragmentation and flow cytometric analysis should be correlated with these changes.
Our study shows that exposure of CCRF-CEM.f2 cells to five anti-cancer drugs induced cell death by apoptosis, although the kinetics varied for each drug. Some studies of cytotoxic drug treated cells report necrotic patterns of cell death but only one criterion was employed by some (Vedeckis and Bradshaw, 1983; Dyson et al., 1986) . Furthermore, drug concentration was also shown to affect the mode of cell death (Lennon et al., 1991; Raffray and Cohen, 1991) . cell death typical of apoptosis has been shown to vary according to the time and concentration of drug exposure (Kaufmann, 1989; Barry et al., 1990) . Similarly, times of appearance of DNA ladders on agarose gels varied between 2 and 48 h for etoposide-treated cells, depending on the cell line studied (Kaufmann, 1989; Barry et al., 1990; Marks and Fox, 1991) . Variations in the time of appearance of apoptotic cells were also recorded after cytosine arabinoside treatment (Kaufmann, 1989; Gunji et al., 1991) . In our study the apoptotic patterns of cell death appeared at similar times for each drug at high concentrations. However, there was no DNA cleavage detected on agarose gels 48 h after exposure at the lowest concentrations of MTX (10-8 M) and FUdR (4 x l08 M), despite extensive inhibition of growth and an increase in the proportion of apoptotic nuclei detected morphologically and by flow cytometry (Figures 2 and 3a-d Further support for this concept comes from studies using the bcl-2 oncogene. The expression of bct-2 suppressed apoptosis induced by cytotoxic drug treatment but the initial biochemical effects still persisted (Fisher et al., 1993; Kamesaki et al., 1993; Oliver et al., 1993; Walton et al., 1993) . For instance, FUdR exposure caused induction of strand breaks, and reduced dTTP and thymidylate synthase activity. These FUdR-induced changes were present in both control and bcl-2 expressing cells yet the latter remained viable, indicating that the bcl-2 gene acts downstream of the initial lesion and before endonucleolytic cleavage of DNA (Fisher et al., 1993) .
Mutations in the tumour-suppressor gene p53 are found in many tumours and tumour cell lines including CCRF-CEM.f2 cells (Cheng and Haas, 1990) . The p53 protein has been shown to suppress cell cycle progression and induce cell death by apoptosis (Lane, 1992) . However despite the loss of p53 function in CEM cells apoptosis still occurs. It seems that only high drug concentrations induce the apoptotic process in cells without p53 expression (Lowe et al., 1993) . Smets (1994) 
